Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China

SAN FRANCISCO and SUZHOU, China, June 1, 2021 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801),…

Cango Inc. Reports First Quarter 2021 Unaudited Financial Results

SHANGHAI, June 1, 2021 /PRNewswire/ — Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading…